O
APTX

OrbiMed’s Aptinyx Inc. Common Stock APTX Stock Holding History

OrbiMed’s Portfolio APTX Stock Details APTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-538,500
Closed -$300K – 151
2022
Q2 		$300K Hold
538,500
– – 0.01% 143
2022
Q1 		$1.22M Sell
538,500
-211,000
-28% -$632K 0.02% 136
2021
Q4 		$2M Buy
749,500
+596,215
+389% +$1.43M 0.03% 151
2021
Q3 		$359K Buy
+153,285
New +$391K ﹤0.01% 170
2020
Q2 		– Sell
-1,162,108
Closed -$2.51M – 162
2020
Q1 		$2.51M Buy
1,162,108
+1,019,108
+713% +$3.33M 0.04% 124
2019
Q4 		$489K Buy
+143,000
New +$492K 0.01% 134

Other funds holding APTX

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $443M AUM 49.46% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

OrbiMed's APTX Position: Q3 2022 in Review

OrbiMed sold out of Aptinyx Inc. Common Stock (APTX) in Q3 2022, closing a stake of 538,500 shares — an estimated $300K sold.

OrbiMed first reported a position in APTX in Q4 2019 and held it in 6 quarters. The position peaked at $2.51M in Q1 2020. 40 funds tracked by Wall St. Rank hold APTX as of Q3 2022.

  • OrbiMed reported no remaining Aptinyx Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • OrbiMed sold 538,500 Aptinyx Inc. Common Stock shares in Q3 2022, an estimated $300K.
  • OrbiMed first reported a position in Aptinyx Inc. Common Stock in Q4 2019 and held it in 6 quarters.
  • OrbiMed's Aptinyx Inc. Common Stock position peaked at $2.51M in Q1 2020.
  • 40 funds tracked by Wall St. Rank held Aptinyx Inc. Common Stock as of Q3 2022.

Based on OrbiMed's 13F filing for Q3 2022, filed 14 Nov 2022.